# Page 128 Audit — References 451-468: Methodology, GRADE, Cochrane Reviews (4 Spans) — FINAL PAGE

## Page Identity
- **PDF page**: S127 (References — www.kidney-international.org) — **FINAL PAGE OF DOCUMENT**
- **Content**: References 451-468 — JADE Registry, CKD management quality, J-DOIT3, IOM guideline standards, GRADE methodology, AGREE II, Cochrane systematic review protocols, risk of bias tools, meta-analysis methods
- **Clinical tier**: T3 (Informational — bibliographic citations + methodology references)
- **Job ID**: df538e50-0170-4ef8-862d-5b0a7c48e4ff
- **Disagreement flag**: NO

## Extraction Summary
| Metric | Value |
|--------|-------|
| Total spans | 4 |
| T1 (Patient Safety) | 0 |
| T2 (Clinical Accuracy) | 4 |
| T3 (Informational) | 0 |
| Channels present | F (NuExtract LLM), C (Grammar/Regex) |
| Accept button | **ENABLED** — Zero T1 spans, no gate blocking ACCEPT |
| Tier accuracy | 0% (0/4) |
| Disagreements | 0 |
| Review Status | PENDING: 4 |
| Audit Date | 2026-02-25 (revised) |
| Cross-Check | 2026-02-25 — counts verified against raw extraction data |

## Key Findings

### Accept Button Enabled — Only Reference Page Without T1 Gate
Page 128 is the **only page in the entire References section** (pages 118-128) where the Accept button is enabled. All other reference pages had T1 spans from the B channel's drug name extraction that blocked ACCEPT. Page 128 has zero T1 spans because none of the reference titles (451-468) contain drug names — they cover methodology and systematic review topics.

### No B Channel — No Drug Names in Methodology References
Like page 127, the B (Drug Dictionary) channel is absent. References 451-468 are exclusively about evidence methodology (GRADE, Cochrane handbook, AGREE II, risk of bias, meta-analysis inconsistency) and systematic review protocols — no specific drug names appear in any title.

### T2 Spans (4)
- **F 85%**: "Quality of chronic kidney disease management in Canadian primary care." — ref 452 title (JAMA Network Open)
- **C 85%**: "Potassium" — lab/electrolyte term extracted from ref 461 title ("Potassium binders for chronic hyperkalaemia in people with chronic kidney disease")
- **F 85%**: "GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology" — ref 464 title (GRADE methodology)
- **F 90%**: "467. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560." — ref 467 full citation (I² statistic paper)

### No HTML Artifact
No `<!-- PAGE 128 -->` HTML artifact on the final page.

### Document Terminus
The PDF content ends with "Kidney International (2022) 102 (Suppl 5S), S1–S127" confirming this is the final page (S127) of the supplement. Reference 468 (GRADE resource use guidelines) is the last citation in the document.

## PDF Source Content
- **Refs 451-454**: JADE Registry quality, Canadian CKD management, J-DOIT3 multifactorial intervention
- **Refs 455-457**: Guideline methodology (IOM trustworthy guidelines, GRADE evidence grading, AGREE II)
- **Refs 458-462**: Cochrane systematic review protocols (direct renin inhibitors, glucose-lowering in transplant, dietary salt, potassium binders, dietary interventions)
- **Refs 463-468**: Cochrane handbook, GRADE series, risk of bias tools, meta-analysis inconsistency (I²), GRADE resource use

## Decision Recommendation
**ACCEPT** — Zero clinical safety risk. All 4 spans are lab terms/ref titles from methodology and systematic review references. Accept button is already enabled.

## Audit Metadata
- **Audited**: 2026-02-24
- **Method**: Playwright browser UI (Phase 2B Page Browse)
- **Auditor**: Claude (automated)
- **Page in sequence**: 128 of 126 (final page — **AUDIT COMPLETE**)
